TNFSF10 and renal carcinoma: In the present study, Caki-1 cells were treated with the anticancer drug cisplatin or TRAIL after miR-1208 transfection, but further studies are required to develop a smart delivery vehicle that can carry these types of anticancer agents into renal cancer cells in vitro and in vivo.